MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Pacific Biosciences of California Shares 2011-2026 | PACB
Annual Shares Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 300 M | 274 M | 254 M | 225 M | 204 M | 165 M | 153 M | 135 M | 106 M | 89.1 M | 75.6 M | 70.5 M | 62.8 M | 55.7 M | 53.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 300 M | 53.9 M | 148 M |
Quarterly Shares Pacific Biosciences of California
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 301 M | 300 M | 294 M | 273 M | 272 M | 270 M | 268 M | 255 M | 250 M | 242 M | 227 M | 225 M | 224 M | 222 M | 221 M | 202 M | 199 M | 195 M | 192 M | 167 M | 154 M | 153 M | 153 K | 153 K | 153 K | 151 M | 149 K | 135 M | 132 M | 124 M | 116 M | 116 M | 97.4 M | 93 M | 92.7 M | 92.1 M | 88.1 M | 83.6 M | 78.3 M | 75.2 M | 74.7 M | 74.1 M | 73.9 M | 70.7 M | 70.5 K | 67.9 M | 66.3 M | 65.5 M | 61.9 M | 57.4 M | 56.2 M | 55.9 M | 55.7 M | 55.2 M | 55 K | 54.3 M | 53.4 K | 55 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 301 M | 53.4 K | 130 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
304 M | $ 114.31 | -0.45 % | $ 34.8 B |  USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 25.04 | 1.25 % | $ 696 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 17.7 | -0.7 % | $ 943 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
713 M | $ 190.78 | -0.68 % | $ 136 B | USA |
 |
DexCom
DXCM
|
390 M | $ 63.36 | 0.24 % | $ 24.7 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.29 | -0.09 % | $ 175 M |  China |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 169.42 | 0.65 % | $ 8.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.22 | -1.22 % | $ 490 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
130 M | $ 14.55 | -5.27 % | $ 1.89 B | USA |
 |
Guardant Health
GH
|
125 M | $ 92.32 | 2.97 % | $ 11.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 107.96 | -1.51 % | $ 8.9 B |  Irlanda |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B |  Niderland |
 |
Illumina
ILMN
|
159 M | $ 127.38 | -0.28 % | $ 20.3 B | USA |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.66 | 2.63 % | $ 86.3 K | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.14 | -1.38 % | $ 4.92 M | USA |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.15 | - | $ 6.26 M | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.0 | 1.27 % | $ 8.85 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 271.44 | -1.14 % | $ 22.6 B | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 77.49 | 2.1 % | $ 5.23 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 508.02 | 2.42 % | $ 14.7 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 115.16 | 0.82 % | $ 5.38 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.74 | 1.39 % | $ 439 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 8.07 | 0.62 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 10.09 | 5.54 % | $ 2.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.24 | -0.52 % | $ 386 M | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
98.4 M | $ 208.0 | 1.53 % | $ 20.5 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 197.23 | -0.91 % | $ 21.9 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 4.8 | 1.27 % | $ 3.78 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 26.95 | -0.96 % | $ 20 B | Niderland |
 |
Precipio
PRPO
|
1.61 M | $ 26.09 | 0.42 % | $ 41.9 M | USA |
 |
Personalis
PSNL
|
59.3 M | $ 6.14 | -6.69 % | $ 364 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |